COMMUNIQUÉS West-GlobeNewswire

Pediapharm to Present at Bloom Burton & Co. Healthcare Investor Conference
24/04/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, April 24, 2018 (GLOBE NEWSWIRE) -- Pediapharm Inc. (the “Company” or "Pediapharm") (TSXV:PDP) (OTCQB:PDDPF) has been [...]
Coherus BioSciences to Report First Quarter 2018 Financial Results on May 10th
24/04/2018
REDWOOD CITY, Calif., April 24, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today announced that its first quarter 2018 financial results will be released after market close on Thursday, May 10, [...]
Tabula Rasa HealthCare Launches its Optimized Opioid Solution™ to Predict and Prevent Unintentional Opioid Abuse
24/04/2018
BOSTON, April 24, 2018 (GLOBE NEWSWIRE) -- AMCP Annual Meeting - Tabula Rasa HealthCare, Inc., (TRHC) (NASDAQ: TRHC ), a healthcare technology company advancing the field of medication safety, today announced its [...]
Helsinn Group to Present a Poster at Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2018
24/04/2018
Helsinn Group to Present a Poster at Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2018 Poster: Budget Impact of Fixed Combination NEPA for the Prevention of Chemotherapy Induced Nausea and Vomiting Lugano, [...]
Alder BioPharmaceuticals® Presents New 12-Month Data of Eptinezumab in PROMISE 1 Phase 3 Trial Showing Long-Term Reduction in Episodic Migraine
24/04/2018
- Data presented at AAN Annual Meeting demonstrate eptinezumab further reduces migraine risk following the third and fourth quarterly infusions - More than 50% of patients achieved a 75% reduction or greater of migraine [...]
Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina Lineberger Advanced Cellular Therapeutics Facility for X-Series™ Products That Provide Automated, Closed System Cellular Processing
24/04/2018
RANCHO CORDOVA, Calif., April 24, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that [...]
Yield10 Bioscience Announces Plans for its 2018 Field Test Program
24/04/2018
WOBURN, Mass., April 24, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, today [...]
Advanced Proteome Therapeutics Announces Appointment of Scientific Advisory Board Members
24/04/2018
VANCOUVER, British Columbia, April 24, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV:APC) (FSE:0E8) is pleased to announce the appointments of two new members to its [...]
Tower One Receives Warrant Exercise Proceeds of $2,166,300.00
24/04/2018
VANCOUVER, British Columbia, April 24, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announces it has received gross proceeds of $2,166,300.00 [...]
MJ Biotech Inc. Current & Future Business Operations
24/04/2018
CHEYENNE, Wyo., April 24, 2018 (GLOBE NEWSWIRE) -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) announced that the Corporate Executives Maxine Pierson CEO of MJ Biotech, Inc. and Fernando Lopez COO [...]
Finalists Announced for 2018 Diabetes Innovation Challenge
24/04/2018
Winners of $250,000 in Cash and In-Kind Prizes to be Announced at Live Event in Boston May 21 BOSTON, April 24, 2018 (GLOBE NEWSWIRE) -- T1D Exchange , a nonprofit patient-centered research organization dedicated to [...]
The Epilepsy Foundation Launches a New Research Study to Find Biomarkers for Treatment of Focal Seizures in People with Epilepsy
24/04/2018
New Study to Enroll 200 Participants across the U.S. with Treatment-Resistant Focal Seizures LANDOVER, Md., April 24, 2018 (GLOBE NEWSWIRE) -- The Epilepsy Foundation today announced the launch of a new Human Epilepsy [...]
TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of Ublituximab (TG-1101) in Patients with Multiple Sclerosis at the American Academy of Neurology 70th Annual Meeting
24/04/2018
Data on now up to 48 patients through 24 weeks confirms previously reported positive results NEW YORK, April 24, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ), today announced updated results from the [...]
Avid Bioservices Provides Update on Ongoing Expansion of Process Development Capabilities and Laboratory Infrastructure
24/04/2018
E nhancements Support New Customer Acquisition Efforts, Highlighted by Recent Signing of Three New Process Development and Manufacturing Agreements TUSTIN, Calif., April 24, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, [...]
Organovo to Present at 2nd Annual NASH Summit
24/04/2018
SAN DIEGO, April 24, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today announced that it will present at the 2nd Annual NASH Summit in Boston, Ma. on Tuesday, April 24th at 4:00pm ET. [...]
Catalyst Pharmaceuticals Introduces New Corporate Website
24/04/2018
CORAL GABLES, Fla., April 24, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and commercializing innovative therapies for people [...]
Foamix Pharmaceuticals First Quarter Financial Results Conference Call & Webcast Scheduled for May 9
24/04/2018
REHOVOT, Israel, and BRIDGEWATER, N.J., April 24, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]
Retrotope Announces RT001 Clinical Data Presentation at the 2018 American Academy of Neurology (AAN) Annual Meeting
24/04/2018
Positive Findings from Compassionate Use Study in Patient with Infantile Neuroaxonal Dystrophy (INAD) Presented LOS ALTOS, Calif., April 24, 2018 (GLOBE NEWSWIRE) -- Retrotope announced today positive findings from a [...]
Golden Leaf Holdings Signs Letter of Intent to Acquire California Cannabis Operation
24/04/2018
Transaction would provide entry into U.S.’s largest growth market for medical and adult-use cannabis TORONTO, April 24, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) ( [...]

Pages